NRX Pharmaceuticals, Inc. (NRXP)
3.04
0.00 (0.00%)
USD |
NASDAQ |
May 06, 16:00
3.04
0.00 (0.00%)
After-Hours: 20:00
NRX Pharmaceuticals EPS Diluted (Quarterly) : 0.0113 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Synergy CHC Corp. | -1.311 |
| IGC Pharma, Inc. | -0.0076 |
| Lantern Pharma, Inc. | -0.362 |
| Vivos Therapeutics, Inc. | -0.7424 |
| Definium Therapeutics, Inc. | -0.5106 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.36M |
| Revenue (Quarterly) | 0.983M |
| Total Expenses (Quarterly) | 0.623M |
| Enterprise Value | 93.36M |
| Gross Profit Margin (Quarterly) | 48.32% |
| Profit Margin (Quarterly) | 36.62% |
| Earnings Yield | -51.64% |
| Normalized Earnings Yield | -28.08 |